换一批Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate.
第一作者：
J M,Perel
第一单位：
Queensland Health Pathology Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
作者：
医学主题词
急性病(Acute Disease);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯甲酰胺类(Benzamides);骨髓(Bone Marrow);克隆细胞(Clone Cells);阿糖胞苷(Cytarabine);疾病恶化(Disease Progression);致命性结局(Fatal Outcome);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);羟基脲(Hydroxyurea);原位杂交, 荧光(In Situ Hybridization, Fluorescence);干扰素类(Interferons);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样(Leukemia, Myeloid);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);男(雄)性(Male);中年人(Middle Aged);肿瘤干细胞(Neoplastic Stem Cells);费城染色体(Philadelphia Chromosome);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);遗传选择(Selection, Genetic);阿糖腺苷(Vidarabine)
PMID
16266916
发布时间
2015-11-19
- 浏览0
Haematologica
ECR25页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
